Media coverage
1
Media coverage
Title Flamingo Therapeutics Presents Poster At ASCO 2024 On Phase II PEMDA-HN Trial For Head And Neck Squamous Cell Carcinoma (HNSCC) Media name/outlet MENAFN -Press Releases (English) Country/Territory Jordan Date 2/06/24 Persons Marshall Posner